ImmunoPrecise Antibodies Ltd.

Latest

Jul 15, 2019, 08:30 ET ImmunoPrecise Antibodies Announces Immuno-oncology Discovery Collaboration with Entos Pharmaceuticals

VICTORIA, July 15, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTC PINK: IPATF), an industry leader in the discovery of novel, therapeutic monoclonal...


Jun 26, 2019, 08:15 ET ImmunoPrecise Guarantees Success for Customers of Their Well-Established B cell Select™ Antibody Discovery Platform

VICTORIA, June 26, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTC PINK: IPATF), the industry leader in the discovery of novel, therapeutic monoclonal...


May 30, 2019, 08:30 ET ImmunoPrecise Antibodies Announces an Unprecedented Onboarding of Pharma and Biotech Clients Using IPA's Proprietary High-Throughput B-Cell Select™ and DeepDisplay™

The Diversified Offerings of 9 Transgenic Animal Strains Platforms supports Solid Growth in Drug Discovery Services VICTORIA, May 30, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or...


Apr 25, 2019, 08:30 ET ImmunoPrecise Antibodies' Subsidiary U-Protein Express Announces Exclusive Agreement as Global Supplier for Wnt-Surrogate-Fc Growth Factor

VICTORIA, April 25, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTC PINK: IPATF) U-Protein Express, a wholly-owned ImmunoPrecise Antibodies subsidiary, in...


Apr 16, 2019, 08:30 ET ImmunoPrecise to Present at the 2019 Bloom Burton & Co. Healthcare Investor Conference

VICTORIA, April 16, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTC PINK: IPATF) announced today that Jennifer Bath, President and CEO of ImmunoPrecise...


Apr 11, 2019, 08:30 ET ImmunoPrecise Appoints Andy Nixon to Board of Directors

VICTORIA, April 11, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTC PINK: IPATF) announces that it has appointed Andy Nixon, Vice President of...


Apr 09, 2019, 08:30 ET TetraGenetics and ImmunoPrecise extend collaboration by signing multi-target service agreement for the Discovery of Therapeutic Antibodies

VICTORIA, April 9, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTC PINK: IPATF) is pleased to announce the extension of its collaboration with...


Apr 04, 2019, 08:30 ET ImmunoPrecise Antibodies Leverages Proprietary Technology and Expertise to Create Talem Therapeutics

VICTORIA, April 4, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTC PINK: IPATF) announces it has formed a wholly-owned, Cambridge, Massachusetts-based...


Apr 03, 2019, 20:32 ET ImmunoPrecise Antibodies Ltd. Announces Trading on OTCQB® Venture Market

VICTORIA, April 3, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTC PINK: IPATF) is pleased to announce that its common shares have been approved for...


Apr 02, 2019, 08:54 ET ImmunoPrecise Launches DeepDisplay(™) Antibody Discovery Platform

ImmunoPrecise Launches Large-Scale Discovery Program with US Pharma Company VICTORIA, April 2, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTC PINK: IPATF) ...


Mar 27, 2019, 18:26 ET ImmunoPrecise Antibodies Reports Record Q3 2019 Financials Results

- Revenues Up 228% For The First 9 Months of Fiscal 2019 VICTORIA, March 27, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "ImmunoPrecise") (TSX VENTURE: IPA) (OTC PINK: IPATF) today...


Mar 15, 2019, 13:47 ET ImmunoPrecise Antibodies Announces Resignation of Jos Raats, as Managing Director of ModiQuest Research BV

VICTORIA, BC, March 15, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTC PINK: IPATF) today announces that Jos Raats, Ph.D., has resigned from the position...


Feb 28, 2019, 09:00 ET ImmunoPrecise Antibodies Announces DTC Eligibility

VICTORIA, BC, Feb. 28, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTC PINK: IPATF) is pleased to announce that its common shares are now eligible for...


Feb 21, 2019, 08:30 ET ImmunoPrecise Antibodies Receives Subcontract to Produce Rabbit Monoclonal Antibodies

VICTORIA, Feb. 21, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTC PINK: IPATF) has received a five-year Indefinite Delivery/Indefinite Quantity (ID/IQ)...


Feb 19, 2019, 08:30 ET ImmunoPrecise Antibodies Collaborates with FIND to Help Advance New TB Diagnostic Test

VICTORIA, Feb. 19, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTC PINK: IPATF) announces the publication of the results of a research collaboration...


Feb 14, 2019, 09:00 ET Second US Office for ImmunoPrecise Antibodies, Ltd. in Cambridge, Massachusetts

VICTORIA, Feb. 14, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTC PINK: IPATF) has announced that they have opened a new subsidiary office in Cambridge,...


Feb 05, 2019, 08:45 ET ImmunoPrecise Antibodies Ltd. Increases Antibody Discovery Capabilities with Addition of Integrated Laboratory Equipment for High-throughput Antibody Screening

VICTORIA, Feb. 5, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTC PINK: IPATF) has announced the purchase of its second state-of-the-art Intellicyt® iQue...


Jan 14, 2019, 08:30 ET ImmunoPrecise Appoints Lisa Helbling as Chief Financial Officer

VICTORIA, Jan. 14, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTC PINK: IPATF) is pleased to announce that it has appointed Lisa Helbling as Chief...


Jan 03, 2019, 13:33 ET ImmunoPrecise Antibodies Will Be in San Francisco During J.P. Morgan Healthcare Conference Week January 7-10, 2019

VICTORIA, Jan. 3, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE IPA) (OTC PINK IPATF) announced today IPA will be in San Francisco during the J.P. Morgan 37th...


Dec 31, 2018, 16:01 ET Immunoprecise Doubles Q2 Revenue From Q2 2017

VICTORIA, Dec. 31, 2018 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "ImmunoPrecise") (TSX VENTURE: IPA) (OTC PINK: IPATF) today reports its financial results for Q2 ended October 31, 2018....


Dec 26, 2018, 08:30 ET ImmunoPrecise Hires Jason Orloske as Vice President Operations

VICTORIA, Dec. 26, 2018 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTC PINK: IPATF) is pleased to announce Jason Orloske has accepted the position of Vice...


Nov 21, 2018, 18:33 ET ImmunoPrecise Announces Results of Annual General Meeting

VICTORIA, Nov. 21, 2018 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. ("ImmunoPrecise" or "IPA") (TSX VENTURE: IPA)(OTC PINK: IPATF) announces that all resolutions were passed by the shareholders at its...


Oct 29, 2018, 08:00 ET ImmunoPrecise Antibodies Ltd. Announces Genetic Immunization Platform

Closes Conversion of $1.377 Million of Debentures VICTORIA, Oct. 29, 2018 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTC PINK: IPATF) is excited to expand its...


Oct 15, 2018, 08:30 ET ModiQuest to Offer Ligand's OmniAb Service in Europe

VICTORIA, Oct. 15, 2018 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTC PINK: IPATF) announces that ModiQuest® Research, an ImmunoPrecise Company, is now an...


Oct 09, 2018, 08:30 ET ImmunoPrecise Signs Large Pharma Antibody Development Agreement

VICTORIA, Oct. 9, 2018 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTC PINK: IPATF) is pleased to announce that it has signed an agreement and initiated an...